Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.
M Furtado, ML Wang, B Munneke… - British Journal of …, 2015 - search.ebscohost.com
M Furtado, ML Wang, B Munneke, J McGreivy, DM Beaupre, S Rule
British Journal of Haematology, 2015•search.ebscohost.comThe article discusses a study revealing association of lymphocytosis with Ibrutinib that leads
to bone marrow involvement in mantle cell lymphoma (MCL). It states that in clinical trials,
ibrutinib acted significantly in B-cell malignancies such as chronic lymphocytic leukaemia
and MCL. It shows an association between lymphocytosis and bone marrow disease
involvement.
to bone marrow involvement in mantle cell lymphoma (MCL). It states that in clinical trials,
ibrutinib acted significantly in B-cell malignancies such as chronic lymphocytic leukaemia
and MCL. It shows an association between lymphocytosis and bone marrow disease
involvement.
Abstract
The article discusses a study revealing association of lymphocytosis with Ibrutinib that leads to bone marrow involvement in mantle cell lymphoma (MCL). It states that in clinical trials, ibrutinib acted significantly in B-cell malignancies such as chronic lymphocytic leukaemia and MCL. It shows an association between lymphocytosis and bone marrow disease involvement.
search.ebscohost.com